Oculis

Developer of therapeutics for the treatment of ophthalmic conditions

placePully, Vaud, Switzerland calendar_todayFounded 2003 groups2 employees language oculis.com

Registered entities

Social engagement

Social engagement: 7.2K social following, 7 posts in the last 12 months — above the industry median.

Investor mix

15 investors on record; lead investors include Bay City Capital, Novartis Venture Fund, Pivotal bioVenture Partners China, Tekla Capital Management; 1 has since exited.

Investor typeCountShare
Venture capital960%
Private equity17%
Angel & family office17%
Other / undisclosed427%

Recent activity

26 Jun 2026
Event
12th Congress of the European Academy of Neurology (#EAN)
11 Jun 2026
Event
Clinical Trials at the Summit (CTS) 2026
8 Jun 2026
Event
Goldman Sachs 47th Annual Global Healthcare Conference
Coming soon